People

Raphael Szalat is a hematologist and Director of the Multiple Myeloma Program and the Stem Cell Transplant Program at Boston Medical Center, and Assistant Professor of Hematology and Oncology at the Boston University Chobanian & Avedisian School of Medicine. He develops myeloma clinical trials and leads basic and translational research in multiple myeloma and other plasma cell disorders, including AL amyloidosis and monoclonal gammopathy of clinical significance.

He trained in medicine in Paris (Université Pierre et Marie Curie and Université Paris-Sorbonne), completed a residency in internal medicine with a focus on clinical immunology and plasma cell disorders, and served as a clinical assistant professor in immuno-hematology at Hôpital Saint-Louis. His 2010 medical thesis on xanthomatosis and monoclonal immunoglobulins received the Paris University Silver Medal.

He completed his PhD and postdoctoral training in hematology at the Dana-Farber Cancer Institute and Harvard Medical School, in collaboration with Université Paris-Sorbonne, studying myeloma genomics and DNA repair, followed by a clinical fellowship in hematology and oncology at Boston Medical Center.

His research uses genomics, epigenomics, and single-cell approaches to study plasma cell disorders across the spectrum from MGUS to multiple myeloma and AL amyloidosis.

Boston Medical Center profile · BU Profiles